Ghost Tree Capital’s Neurogene NGNE Stock Holding History

Ghost Tree Capital’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.1M	Sell	50,000 -20,000	-29%	-$776K	0.63%	44
2024 Q2	$2.55M	Buy	70,000 +45,000	+180%	+$1.59M	0.8%	41
2024 Q1	$1.27M	Buy	+25,000	New	+$835K	0.35%	64
2018 Q4	–	Sell	-25,000	Closed	-$1.47M	–	53
2018 Q3	$1.47M	Buy	+25,000	New	+$1.47M	0.31%	46
2018 Q2	–	Sell	-20,000	Closed	-$5.63M	–	54
2018 Q1	$5.63M	Hold	20,000	–	–	1.14%	29
2017 Q4	$4.7M	Hold	20,000	–	–	1.1%	32
2017 Q3	$5.68M	Buy	20,000 +5,000	+33%	+$1.44M	1.21%	32
2017 Q2	$4.22M	Buy	15,000 +3,750	+33%	+$1.07M	0.88%	42
2017 Q1	$3.75M	Hold	11,250	–	–	0.7%	49
2016 Q4	$3.71M	Sell	11,250 -1,250	-10%	-$336K	0.89%	45
2016 Q3	$3.34M	Buy	+12,500	New	+$2.52M	0.54%	55

Other funds holding NGNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Ghost Tree Capital's NGNE Position: Q3 2024 in Review

Ghost Tree Capital reduced its Neurogene (NGNE) stake by 29% in Q3 2024, selling an estimated $776K and leaving 50,000 shares worth $2.1M. The position accounts for 0.63% of the portfolio, ranked #44.

Ghost Tree Capital first reported a position in NGNE in Q3 2016 and has held it in 11 quarters since. The position peaked at $5.68M in Q3 2017. 86 funds tracked by Wall St. Rank hold NGNE as of Q3 2024.

Ghost Tree Capital held 50,000 shares of Neurogene worth $2.1M as of Q3 2024.
Ghost Tree Capital sold 20,000 Neurogene shares in Q3 2024, an estimated $776K.
Neurogene made up 0.63% of Ghost Tree Capital's portfolio in Q3 2024, its #44 holding.
Ghost Tree Capital first reported a position in Neurogene in Q3 2016 and has held it in 11 quarters since.
Ghost Tree Capital's Neurogene position peaked at $5.68M in Q3 2017.
86 funds tracked by Wall St. Rank held Neurogene as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.